6 min read

Service Corporation International (SCI) Latest Financial and Strategic Update

by monexa-ai

Explore Service Corporation International's recent financial results, strategic shifts in pre-need contracts, and dividend sustainability amid demographic tailwinds.

Elegant urn with metallic finish on a marble surface against a soft purple background

Elegant urn with metallic finish on a marble surface against a soft purple background

Introduction: Service Corporation International's Current Market Position#

Service Corporation International (SCI recently reported a slight stock price decline to $81.40, reflecting a -0.31% change, yet its financial fundamentals and strategic initiatives continue to attract investor attention. The company's market capitalization stands robustly at $11.59 billion, underscoring its significant presence in the deathcare industry. With CEO Thomas L. Ryan at the helm, SCI navigates an evolving landscape marked by demographic shifts and operational transitions that have implications for its future revenue and profitability.

Professional Market Analysis Platform

Make informed decisions with institutional-grade data. Track what Congress, whales, and top investors are buying.

AI Equity Research
Whale Tracking
Congress Trades
Analyst Estimates
15,000+
Monthly Investors
No Card
Required
Instant
Access

Key Financial Developments and Earnings Overview#

SCI's most recent fiscal year data through 2024 reveals nuanced shifts in its financial metrics. Revenue rose modestly by +2.11% year-over-year to $4.19 billion, while net income experienced a -3.47% decline to $518.65 million. The company's operating income margin compressed slightly to 22.16%, down from 23.03% in 2023, indicating tighter operating efficiencies or margin pressures. Despite this, SCI maintains a solid gross profit ratio of 26.05% and a net income ratio of 12.39%, reflective of its ongoing profitability in a competitive sector.

In terms of earnings per share (EPS), SCI reported a trailing twelve months (TTM) EPS of $3.68, consistent with prior periods, and a price-to-earnings (P/E) ratio around 22.12x, slightly above industry median benchmarks. The company is expected to announce earnings on July 29, 2025, with previous quarterly earnings surprises showing slight outperformance, such as the April 2025 beat where actual EPS was $0.96 versus an estimate of $0.90.

Financial Performance Table: Fiscal Years 2021-2024#

Fiscal Year Revenue (Billion USD) Net Income (Million USD) Operating Income (Million USD) Gross Profit Ratio Net Income Ratio EPS (TTM) P/E Ratio (TTM)
2021 4.14 802.94 1,190 31.46% 19.38% 3.68 22.12x
2022 4.11 565.34 927 28.10% 13.76% 3.68 22.12x
2023 4.10 537.32 944 26.63% 13.11% 3.68 22.12x
2024 4.19 518.65 928 26.05% 12.39% 3.68 22.12x

Strategic Shift: Transition to Insurance-Funded Pre-Need Contracts#

A significant development for SCI is its ongoing transition from trust-funded to insurance-funded pre-need contracts, primarily within the SCI Direct segment. This shift, intended to improve revenue predictability and margin expansion, has introduced short-term challenges including a reported -10% decline in pre-need sales during Q1 2025.

Management anticipates stabilization by late 2025, with stronger growth in 2026 driven by higher commissions and operational efficiencies. This strategic pivot aligns with SCI’s goal to secure more stable and profitable long-term cash flows amid evolving consumer financing preferences.

Dividend Policy and Shareholder Returns#

SCI maintains a disciplined dividend policy with a current quarterly dividend of $0.32 per share as of June 2025, marking a 4.8% increase from the previous payout. The company’s dividend yield stands at approximately 1.52%, supported by a conservative payout ratio near 33.26%. This payout level is sustainable given SCI’s free cash flow generation, which reached about $555.8 million in 2024, indicating strong liquidity to support dividends and share repurchases.

Dividend History and Sustainability Table#

Date Dividend Per Share Dividend Yield Payout Ratio Free Cash Flow (Million USD)
June 2025 $0.32 1.52% 33.26% $555.8
March 2025 $0.32 1.52% 33.26% $555.8
Dec 2024 $0.30 1.50% 32.50% $555.8
Sep 2024 $0.30 1.50% 32.50% $555.8

Competitive Landscape and Market Position#

SCI commands a dominant footprint in the North American deathcare sector, operating approximately 2,000 funeral homes and cemeteries. This scale provides economies of scale and geographic clustering benefits, enhancing cost efficiencies and bargaining power. The company's strategy of acquiring smaller, fragmented operators supports market share expansion, currently estimated at around 7.5% of locations and 15% of revenue in the region.

The deathcare industry is characterized by steady demand driven by demographic trends, notably the aging Baby Boomer generation. SCI’s pre-need sales focus enables revenue stability by securing contracts in advance, mitigating cyclical risks.

Financial Health and Capital Structure#

Despite a relatively low current ratio of 0.51x, SCI manages its liquidity effectively, supported by $218.77 million in cash and equivalents as of the end of 2024. The company’s total debt stands at $4.92 billion, with a net debt to EBITDA ratio of approximately 3.84x, reflecting moderate leverage consistent with industry norms.

Return on equity (ROE) remains robust at 32.65%, signaling efficient capital utilization. However, return on invested capital (ROIC) is modest at 4.32%, suggesting room for improvement in generating returns from invested assets.

Analyst Estimates and Future Growth Prospects#

Analyst consensus projects gradual revenue growth, with a 2025 estimated revenue of approximately $4.29 billion and EPS forecast at $3.78. Forward-looking P/E ratios are expected to decline modestly to 20.86x in 2025 and further to 16.51x by 2027, reflecting anticipated earnings growth and valuation normalization.

The company's future revenue compound annual growth rate (CAGR) is forecasted at +3.28%, with EPS growth expected at +8.42% annually through 2027. These projections align with SCI's strategic initiatives to expand its market share and operational efficiencies.

What Drives SCI’s Dividend Sustainability and Growth?#

SCI’s dividend sustainability is underpinned by strong free cash flow generation, conservative payout ratios, and demographic tailwinds supporting demand for deathcare services. The strategic pivot to insurance-funded pre-need contracts, despite short-term sales impacts, is expected to bolster long-term margin stability.

Operational efficiencies from asset clustering and market consolidation further support profitability and cash flow stability. These factors combined position SCI to continue delivering shareholder value through dividends and potential capital appreciation.

Key Takeaways#

  • Modest revenue growth (+2.11%) in 2024 with a slight net income decline (-3.47%) reflecting margin pressures.
  • Transition to insurance-funded pre-need contracts is a strategic pivot with short-term sales headwinds but potential for margin expansion.
  • Dividend policy remains conservative and sustainable, with a 4.8% recent increase and a payout ratio near 33%.
  • Strong market position in North America with ongoing acquisitions supporting scale and efficiency.
  • Financial leverage and liquidity are in line with industry standards; ROE remains strong though ROIC indicates room for capital efficiency improvement.
  • Analyst forecasts suggest steady revenue and EPS growth with valuation multiples normalizing by 2027.

What This Means For Investors#

Investors should consider SCI's strategic shift in pre-need contracts and its implications for near-term sales and long-term profitability. The company's robust free cash flow and disciplined dividend policy provide a reliable income stream, while demographic trends offer a supportive backdrop for sustainable demand.

Ongoing acquisitions and operational efficiencies enhance SCI's competitive positioning, though investors should monitor margin trends and debt levels for signs of financial flexibility. The balance between short-term transitional challenges and long-term growth potential frames SCI as a company navigating industry evolution with measured strategic execution.

References#

Paycom AI HCM integration with ROI and revenue growth metrics for investors, Q2 2025 performance and future strategy visual

Paycom Software, Inc. — Revenue Acceleration and Margin Lift Backed by AI Adoption

Paycom reported outsized earnings beats and **recurring revenue up ~12%** as AI-driven products (IWant, Beti) lift ARPU and margins while balance-sheet data show unusual financing flows.

Sprouts Farmers Market $1B buyback analysis: e-commerce and wellness growth, stronger shareholder value, robust financials,

Sprouts Farmers Market (SFM): $1B Buyback, Cash Flow Strength and a 7% EPS Lever

Sprouts’ board authorized a **$1.00 billion** repurchase on Aug 13, 2025 — roughly **7.0%** of shares at current prices — backed by improving FCF and targeted reinvestment in e‑commerce and private label.

Logo on frosted glass with CdTe panels, Treasury columns, factory silhouette, tax credit icons in purple haze

First Solar (FSLR): Policy Clarity Spurs Revenue and Margin Re-rate

Treasury IRS Notice 2025-42 crystallizes IRA benefits for U.S. manufacturers — First Solar posts **FY2024 revenue $4.21B**, **net income $1.29B** and a balance sheet with **~$1.6B cash**, shifting the investment story to execution and capex intensity.

CNA Financial earnings and dividend analysis with underwriting profit, insurance stability, and value investing in purple

CNA Financial: 8% Yield Meets Improving Underwriting — Dividend Durability in Focus

CNA reported a better P&C combined ratio (94.1%) and an underlying underwriting gain of $213M while paying a $0.46 quarterly dividend that yields ~8% — but payout metrics and data inconsistencies raise sustainability questions.

Logo on frosted glass with molecule models, abstract lungs, rising arrows in purple, symbolizing respiratory drug approval

Insmed (INSM): Brinsupri Launch, Revenue Growth and Balance-Sheet Risks

FDA approval and $88,000 WAC for Brinsupri reshapes revenue potential; 2024 revenue +19.17% to $363.71M but net loss widened to -$913.77M and leverage metrics conflict.

Abstract market trends and analytics visualization with flowing data in a purple gradient

Rivian Automotive (RIVN): Cash Burn, R2 Hinge and Margin Repair

Rivian widened its 2025 adjusted‑EBITDA loss and cut deliveries as FY2024 showed improving margins but continued negative free cash flow and policy-driven shocks.